New diabetes clinical trial: A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fed)
Published on: July 23, 2025 at 11:00PM
Conditions: Diabete Mellitus
Interventions: Drug: Dapagliflozin 10 mg/Pioglitazone 30 mg/Metformin HCl 1000 mg; Drug: Dapagliflozin 10 mg; Drug: Pioglitazone 30 mg; Drug: Metformin HCl 1000 mg
Sponsors: Boryung Pharmaceutical Co., Ltd
Recruiting
https://ift.tt/Y0UzOAC
Conditions: Diabete Mellitus
Interventions: Drug: Dapagliflozin 10 mg/Pioglitazone 30 mg/Metformin HCl 1000 mg; Drug: Dapagliflozin 10 mg; Drug: Pioglitazone 30 mg; Drug: Metformin HCl 1000 mg
Sponsors: Boryung Pharmaceutical Co., Ltd
Recruiting
https://ift.tt/Y0UzOAC
Comments
Post a Comment